In pancreatic cancer, the aberrant homotrimeric variant of Col1 produced by tumor cells exhibits oncogenic properties by downregulating the expression of CXCL16, significantly inhibiting the infiltration and activation of T cells, particularly CD8+ T cells (53). The gene discussed is CXCL16; the disease is pancreatic neoplasm.